Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The displayed site revision advances from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a standard header and footer, replacing the expected study record content. This indicates restricted access to the requested resource.
    Difference
    0.5%
    Check dated 2026-09-26T22:04:41.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows the new revision label Revision: v3.7.0. A large set of previously visible terms—names of institutions and investigators, as well as study-related drugs and concepts—were removed, altering how the study is described and who is represented as involved.
    Difference
    19%
    Check dated 2026-09-19T21:59:24.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the study entry. This appears to be an internal revision with no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:34:30.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Study Record Dates were updated with several entries changing from Estimated to Actual, and the revision tag was updated to Revision: v3.6.5, indicating a new version of the study record.
    Difference
    0.4%
    Check dated 2026-08-08T09:49:24.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.3 to v3.6.4, indicating a software update to the site's tooling. It appears to affect only versioning metadata, not the study details.
    Difference
    0.1%
    Check dated 2026-07-25T06:28:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.